Japanese Patients' Preferences for Receiving Cancer Test Results While in the United States: Introducing an Advance Directive for Cancer Disclosure
dc.contributor.author | Fetters, Michael D. | en_US |
dc.contributor.author | Masuda, Yuichiro | en_US |
dc.date.accessioned | 2009-07-10T19:07:46Z | |
dc.date.available | 2009-07-10T19:07:46Z | |
dc.date.issued | 2000-09-01 | en_US |
dc.identifier.citation | Fetters, Michael D.; Masuda, Yuichiro (2000). "Japanese Patients' Preferences for Receiving Cancer Test Results While in the United States: Introducing an Advance Directive for Cancer Disclosure." Journal of Palliative Medicine 3(3): 361-374 <http://hdl.handle.net/2027.42/63295> | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/63295 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=15859685&dopt=citation | en_US |
dc.description.abstract | Background: While disclosure of cancer is routine in the United States, it is not in Japan. The primary goals of this investigation were to describe overseas Japanese patients' preferences for participation in decisions about cancer; to delineate patients' beliefs about how physicians should make cancer disclosure decisions; and to assess patients' attitudes about a advance directive for cancer disclosure. Methods: This ethnography utilized data from participant observations, 30 interviews, and lay materials. Using the analytic technique of immersion and crystallization the data were organized around major themes and subthemes. Results: The mean age of the 30 participants was 38 years and most (n = 20) were female. While most patients expressed preferences to be told the results of cancer testing, the number who did not want to be told increased with more advanced cancer stage. Many participants believed decisions about disclosure should be influenced by a patient's personality, age, or gender, although the relative importance of these factors was variable. Virtually all believed circumstances existed when fully competent patients should not be told the cancer diagnosis. Most participants were supportive of using an advance directive for cancer disclosure. Discussion: These participants' beliefs about many aspects of the management of cancer test results differ from recommended approaches to conveying cancer test results and discussing the cancer diagnosis in the United States. Most encourage the use of an advance directive for cancer disclosure as mechanism for physicians to elicit patients' unique preferences for participation in decision making about cancer. | en_US |
dc.format.extent | 1534716 bytes | |
dc.format.extent | 2489 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Mary Ann Liebert, Inc., publishers | en_US |
dc.title | Japanese Patients' Preferences for Receiving Cancer Test Results While in the United States: Introducing an Advance Directive for Cancer Disclosure | en_US |
dc.type | Article | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.identifier.pmid | 15859685 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/63295/1/jpm.2000.3.361.pdf | |
dc.identifier.doi | doi:10.1089/jpm.2000.3.361 | en_US |
dc.identifier.source | Journal of Palliative Medicine | en_US |
dc.identifier.source | Journal of Palliative Medicine | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.